BF Biosciences Limited (PSX: BFBIO) Thursday announced that its combi filling and lyophilization lines have been commissioned and commercial production has commenced.
In a notice to the Pakistan Stock Exchange (PSX), citing an earlier communication, the company said that secured approval from Drug Regulatory of Pakistan (DRAP) for its brownfield expansion project along with commencement of commercial production from pre-filled syringes line.
“In continuation of the above, we are pleased to inform that the combi filling and lyophilization lines have been commissioned and commercial production has commenced. Accordingly, the full Line Il expansion project stands commissioned from today,” it said.
Moreover, the company said it has already secured approvals for new products from DRAP and intends to launch these products in the coming months.
Stay Connected with ProPakistani
Get the latest business news, market insights, and economic updates wherever you prefer.
Add ProPakistani to Preferred Sources and see more of our stories in Google Search and Top Stories.
